Exhibit II
to
Schedule 13G
Joint Filing Agreement
The undersigned persons agree and consent to the joint filing on their behalf of this Schedule 13G dated May 11, 2022 in connection with their beneficial ownership of Eiger BioPharmaceuticals, Inc. Each of Seligman Tech Spectrum Offshore Fund, Columbia Seligman Technology and Information Fund and Columbia Management Investment Advisers, LLC authorizes Ameriprise Financial, Inc. to execute the Schedule 13G to which this Exhibit is attached and make any necessary amendments thereto.
Ameriprise Financial, Inc. | ||
By: | /s/ Michael G. Clarke | |
Name: Michael G. Clarke | ||
Title: Senior Vice President, Head of Global Operations | ||
Columbia Management Investment Advisers, LLC | ||
By: | /s/ Michael G. Clarke | |
Name: Michael G. Clarke | ||
Title: Senior Vice President, Head of Global Operations | ||
Seligman Tech Spectrum Offshore Fund | ||
By: | /s/ David Litton | |
Name: David Litton | ||
Title: Director | ||
Columbia Seligman Technology and Information Fund | ||
By: | /s/ Michael G. Clarke | |
Name: Michael G. Clarke | ||
Title: Chief Financial Officer and Principal Financial Officer |